OrthoPediatrics Corp Deferred Income Tax Expense (Benefit)
OrthoPediatrics Corp (KIDS) reported Deferred Income Tax Expense (Benefit) of -$82.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-05
- OrthoPediatrics Corp deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $232.00K, a 373.47% increase year-over-year.
- OrthoPediatrics Corp deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$314.00K, a 260.20% decline year-over-year.
- OrthoPediatrics Corp deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$273.00K.
- OrthoPediatrics Corp deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$125.00K.
- OrthoPediatrics Corp deferred income tax expense (benefit) for fiscal 2025 was -$153.00K.
- OrthoPediatrics Corp deferred income tax expense (benefit) for fiscal 2024 was -$4.74M.
- OrthoPediatrics Corp deferred income tax expense (benefit) for fiscal 2023 was -$1.16M.
- OrthoPediatrics Corp deferred income tax expense (benefit) for fiscal 2022 was -$5.03M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$82.00K 10-Q · filed 2026-08-05 | -$355.00K derived: sum of 3 quarters · filed 2026-08-05 | -$480.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$314.00K 10-Q · filed 2026-05-01 | -$587.00K derived: sum of 2 quarters · filed 2026-05-01 | -$712.00K derived: sum of 3 quarters · filed 2026-05-01 | -$663.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$398.00K derived: sum of 2 quarters · filed 2026-03-04 | -$349.00K derived: sum of 3 quarters · filed 2026-08-05 | -$153.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$76.00K derived: sum of 2 quarters · filed 2026-08-05 | $120.00K 10-Q · filed 2025-10-29 | -$709.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $245.00K 10-Q · filed 2026-08-05 | -$584.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.54M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $196.00K 10-Q · filed 2026-05-01 | -$633.00K derived: sum of 2 quarters · filed 2026-05-01 | -$1.58M derived: sum of 3 quarters · filed 2026-05-01 | -$2.10M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$829.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.78M derived: sum of 2 quarters · filed 2026-03-04 | -$2.29M derived: sum of 3 quarters · filed 2026-03-04 | -$4.74M 10-K · filed 2026-03-04 |
| 2024-09-30 | -$952.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$1.46M derived: sum of 2 quarters · filed 2025-10-29 | -$3.91M 10-Q · filed 2025-10-29 | -$4.17M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | -$510.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.96M 10-Q · filed 2025-08-06 | -$3.22M derived: sum of 3 quarters · filed 2026-03-04 | -$3.14M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | -$2.44M 10-Q · filed 2025-05-08 | -$2.71M derived: sum of 2 quarters · filed 2026-03-04 | -$2.63M derived: sum of 3 quarters · filed 2026-03-04 | -$3.03M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | -$264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$188.00K derived: sum of 2 quarters · filed 2026-03-04 | -$589.00K derived: sum of 3 quarters · filed 2026-03-04 | -$1.16M 10-K · filed 2026-03-04 |
| 2023-09-30 | $76.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$325.00K derived: sum of 2 quarters · filed 2024-11-07 | -$899.00K 10-Q · filed 2024-11-07 | -$1.13M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | -$401.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$975.00K 10-Q · filed 2024-08-06 | -$1.20M derived: sum of 3 quarters · filed 2025-03-05 | -$5.25M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | -$574.00K 10-Q · filed 2024-05-07 | -$802.00K derived: sum of 2 quarters · filed 2025-03-05 | -$4.85M derived: sum of 3 quarters · filed 2025-03-05 | -$5.29M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | -$228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | -$4.28M derived: sum of 2 quarters · filed 2025-03-05 | -$4.71M derived: sum of 3 quarters · filed 2025-03-05 | -$5.03M 10-K · filed 2025-03-05 |
| 2022-09-30 | -$4.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$4.49M derived: sum of 2 quarters · filed 2023-11-07 | -$4.80M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | -$439.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$756.00K 10-Q · filed 2023-08-01 | ||
| 2022-03-31 | -$317.00K 10-Q · filed 2023-05-02 | |||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 | |||
| 2019-12-31 | $0.00 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |